PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 134 filers reported holding PDL BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $73,000 | -9.9% | 23,284 | -16.5% | 0.00% | – |
Q2 2020 | $81,000 | +2.5% | 27,872 | 0.0% | 0.00% | – |
Q1 2020 | $79,000 | -28.8% | 27,872 | -18.0% | 0.00% | – |
Q4 2019 | $111,000 | +52.1% | 33,970 | 0.0% | 0.00% | – |
Q3 2019 | $73,000 | -7.6% | 33,970 | +35.1% | 0.00% | – |
Q2 2019 | $79,000 | -24.8% | 25,136 | -11.0% | 0.00% | – |
Q1 2019 | $105,000 | +36.4% | 28,236 | +5.8% | 0.00% | – |
Q4 2018 | $77,000 | +37.5% | 26,678 | +24.2% | 0.00% | – |
Q3 2018 | $56,000 | +12.0% | 21,481 | 0.0% | 0.00% | – |
Q2 2018 | $50,000 | -38.3% | 21,481 | -22.3% | 0.00% | – |
Q1 2018 | $81,000 | -23.6% | 27,659 | -27.4% | 0.00% | – |
Q4 2017 | $106,000 | -29.8% | 38,085 | -14.4% | 0.00% | – |
Q3 2017 | $151,000 | +49.5% | 44,487 | +10.8% | 0.00% | – |
Q2 2017 | $101,000 | -15.8% | 40,151 | -25.2% | 0.00% | – |
Q1 2017 | $120,000 | -80.7% | 53,700 | -81.7% | 0.00% | -100.0% |
Q4 2016 | $622,000 | -33.5% | 293,356 | +4.7% | 0.00% | 0.0% |
Q3 2016 | $935,000 | +47.9% | 280,214 | +38.9% | 0.00% | 0.0% |
Q2 2016 | $632,000 | +24.2% | 201,737 | +31.7% | 0.00% | 0.0% |
Q1 2016 | $509,000 | -14.2% | 153,167 | -8.6% | 0.00% | 0.0% |
Q4 2015 | $593,000 | +8.0% | 167,504 | +53.4% | 0.00% | 0.0% |
Q3 2015 | $549,000 | -21.8% | 109,166 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $702,000 | -3.7% | 109,166 | +5.6% | 0.00% | 0.0% |
Q1 2015 | $729,000 | +16.8% | 103,357 | +27.8% | 0.00% | 0.0% |
Q4 2014 | $624,000 | +3.5% | 80,845 | +0.4% | 0.00% | 0.0% |
Q3 2014 | $603,000 | +11.7% | 80,503 | +44.3% | 0.00% | 0.0% |
Q2 2014 | $540,000 | +16.4% | 55,786 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $464,000 | -1.5% | 55,786 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $471,000 | +5.8% | 55,786 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $445,000 | +127.0% | 55,786 | +119.8% | 0.00% | – |
Q2 2013 | $196,000 | – | 25,381 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KESTREL INVESTMENT MANAGEMENT CORP | 1,634,000 | $4,804,000 | 1.81% |
SMH CAPITAL ADVISORS INC | 80,722 | $237,000 | 0.37% |
Matarin Capital Management, LLC | 1,126,641 | $3,312,325,000 | 0.25% |
Hillsdale Investment Management Inc. | 337,800 | $993,000 | 0.14% |
Zebra Capital Management LLC | 115,431 | $339,000 | 0.12% |
Connor, Clark & Lunn Investment Management Ltd. | 4,789,702 | $14,082,000 | 0.08% |
Fortis Advisors, LLC | 45,602 | $134,000 | 0.07% |
Municipal Employees' Retirement System of Michigan | 500,080 | $1,470,000 | 0.07% |
RBF Capital, LLC | 173,090 | $508,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 392,276 | $1,153,000 | 0.06% |